Clinical trial · Observational
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
NCT06779747CI-TRIAL-00084841recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Observational single-center prospective and retrospective, nonpharmacological, spontaneous cohort study.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hyperthyroidism/Thyrotoxicosis | — | UNRESOLVED | — |
| Hypothyroidism | — | UNRESOLVED | — |
| Thyroid Carcinoma | Thyroid Gland Carcinoma | ALIAS | 0.90 |
| Thyroid Nodule (Benign) | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Retrospective Group
- description
- The retrospective phase will involve about 2850 patients of whom: * 500 with hypothyroidism; * 500 suffering from hyperthyroidism/thyrotoxicosis; * 1000 affe8ed with benign thyroid nodule; * 850 suffering from thyroid carcinoma.
- label
- Prospective Group
- description
- In the prospective phase, on the other hand, about 3000 patients will be sequentially enrolled, including: * 60/year with hypothyroidism; * 60/year suffering from hyperthyroidism/thyrotoxicosis; * 100/year suffering from benign thyroid nodule; * 80/year suffering from thyroid carcinoma.
Primary outcomes (1)
- measure
- Characterization of Patient Population with Thyroid Disease (Hypothyroidism, Hyperthyroidism, Benign Nodules, Thyroid Carcinoma)
- timeFrame
- through study completion, an average of 17 years
- description
- The primary objective is to describe the characteristics of the patient population followed at our Center for any thyroid disease (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, and thyroid carcinoma), through specific data collection, with the intent to improve their clinical-diagnostic-therapeutic management.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age older than 18 years at the time of diagnosis; * Patients with thyroid pathology (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, and thyroid carcinoma) in whom the diagnosis was made in our Center or another Center from 01/01/1995 until the approval of this study (retrospective phase) or from the time of approval of this study to the next 10 years (prospective phase); * Obtaining informed consent. Exclusion Criteria: * Follow up lasting less than 3 months; * Incomplete or missing clinical data that may affect the correct assessment of the patient.
References
Publications (0)
Data not yet available
No reference posted for this study.